UNLIMITED TURBO BULL - NOVARTIS N Share Price

Certificat

26B3Z

DE000CL5A5F0

Real-time Euronext Paris 14:49:32 03/05/2024 BST
10.13 EUR -0.69% Intraday chart for UNLIMITED TURBO BULL - NOVARTIS N
Current month-0.49%
1 month+5.92%
Date Price Change Volume
03/05/24 10.13 -0.69% 52
02/05/24 10.2 -0.49% 84
30/04/24 10.25 +0.69% 79
29/04/24 10.18 -1.64% 74
26/04/24 10.35 -1.43% 88

Real-time Euronext Paris

Last update May 03, 2024 at 02:49 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
26B3Z
ISINDE000CL5A5F0
Date issued 17/03/2020
Strike 39.1 CHF
Maturity Unlimited
Parity 5 : 1
Emission price 4.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.44
Lowest since issue 4.955
Spread 0.01
Spread %0.10%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.38 USD
Average target price
108.4 USD
Spread / Average Target
+11.36%
Consensus
  1. Stock Market
  2. Certificates
  3. 26B3Z Certificat